References
- Word Health Organization. Noncommunicable diseases. The Word Health Organization Website; 2022 [cited 2023 Jan 31]. Available from: https://www.who.int/news-room/fact-sheets/detail/ noncommunicable-diseases.
- State Council Information Office. Release conference of the report on nutrition and chronic diseases in China 2020; 2020 [cited 2023 Jan 31]. Available from: http://www.scio.gov.cn/xwfbh/xwbfbh/wqfbh/42311/44583/index.htm (in Chinese).
- Nugent R. Preventing and managing chronic diseases. BMJ. 2019;364:l459.
- Martin LR, Williams SL, Haskard KB, et al. The challenge of patient adherence. Ther Clin Risk Manag. 2005;1(3):189–199.
- Sabate E, World Health Organization. Adherence to long-term therapies: evidence for action. 2003 [cited 2023 Jan 31]. Available from: http://apps.who.int/iris/bit-stream/10665/42682/1/9241545992.pdf.
- Kini V, Ho PM. Interventions to improve medication adherence: a review. JAMA. 2018;320(23):2461–2473.
- Kwan YH, Weng SD, Loh D, et al. Measurement properties of existing Patient-Reported outcome measures on medication adherence: systematic review. J Med Internet Res. 2020;22(10):e19179.
- Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.
- Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertension. 2008;10(5):348–354.
- Agbor VN, Takah NF, Aminde LN. Prevalence and factors associated with medication adherence among patients with hypertension in sub-Saharan Africa: protocol for a systematic review and meta-analysis. BMJ Open. 2018;8(3):e20715.
- Naqvi AA, Hassali MA, Rizvi M, et al. Development and validation of a novel General Medication Adherence Scale (GMAS) for chronic illness patients in Pakistan. Front Pharmacol. 2018;9:1124.
- Wang Y, Wang X, Wang X, et al. Translation and validation of the Chinese version of the general medication adherence scale (GMAS) in patients with chronic illness. Curr Med Res Opin. 2021;37(5):829–837.
- Bechger TM, Maris G. A statistical test for differential item pair functioning. Psychometrika. 2015;80(2):317–340.
- Schumacker RE, Jr., Smith EV. Reliability – a Rasch perspective. Educ Psychol Meas. 2007;67(3):394–409.
- Stolt M, Kottorp A, Suhonen R. The use and quality of reporting of Rasch analysis in nursing research: a methodological scoping review. Int J Nurs Stud. 2022;132:104244.
- Horta-Baas G, Vargas-Mena R, Alejandre E, et al. Psychometric properties of the 12-item knee injury and osteoarthritis outcome score (KOOS-12) Spanish version for people with knee osteoarthritis. Clin Rheumatol. 2021;40(4):1547–1558.
- Linacre JM. Sample size and item calibration stability. Rasch measurement transactions; 1994 [cited 2023 Jan 31]. Available from: http://www.rasch.org/rmt/rmt74m.htm. title=Winsteps+Rasch+measurement+computer+program+User%E2%80%99s+guide&author=JM+Linacre&publication_year=2012&.
- Shrestha R, Sapkota B, Khatiwada AP, et al. Translation, cultural adaptation and validation of General Medication Adherence Scale (GMAS) into the Nepalese language. PPA. 2021;15:1873–1885.
- Naqvi AA, Hassali MA, Jahangir A, et al. Translation and validation of the English version of the general medication adherence scale (GMAS) in patients with chronic illnesses. J Drug Assess. 2019;8(1):36–42.
- Linacre JM. Winsteps Rasch measurement computer program user’s guide. Beaverton: Winsteps.com; 2012 [cited 2023 Jan 31]. Available from: https://scholar.google.com/scholar_lookup?
- Liu X, Jane RH. Treatments of differential item functioning: a comparison of four methods. Educ Psychol Meas. 2022;82(2):225–253.
- Yang F, He W, Wang H. Advantages and significance of the single parameter dimension Rasch model. J of Psych Scie. 2021;44(6):1491–1498 (in Chinese).
- Rindskopf D, Bejar II. Achievement testing: recent advances. J Am Stat Assoc. 1985;80(390):482.
- Kang CH, Xin T. New development of test theory: multidimensional item response theory. Adv Psych Scie. 2010;18(03):530–536 (in Chinese).
- Waugh RF, Chapman ES. An analysis of dimensionality using factor analysis (true-score theory) and Rasch measurement: what is the difference? Which method is better? J Appl Meas. 2005;6(1):80–99.
- Liu F, Zhang Z, Lin B, et al. Assessing the psychometric properties of the chinese return-to-work self-efficacy questionnaire using rasch model analysis. Health Qual Life Outcomes. 2022;20(1):27.
- Packham T, MacDermid JC, Selles RW, et al. Rasch analysis of the Michigan Hand Questionnaire. Value Health. 2022;25(4):638–646.
- Cortaredona S, Ventelou B. The extra cost of comorbidity: multiple illnesses and the economic burden of non-communicble diseases. BMC Med. 2017;15(1):216.
- Zerah L, Henrard S, Thevelin S, et al. Performance of a trigger tool for detecting drug-related hospital admissions in older people: analysis from the OPERAM trial. Age Ageing. 2022;51(1):afab196.
- Mason KE, Maudsley G, McHale P, et al. Age-Adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence from the early stages of the pandemic. Front Public Health. 2021;9:584182.